Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report

The Open Colorectal Cancer Journal
doi 10.2174/1876820201003010023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Vascular Endothelial Growth Factor Polymorphisms and Clinical Outcome in Colorectal Cancer Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2011English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients

Frontiers in Oncology
Cancer ResearchOncology
2019English

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2011English

Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly

British Journal of Cancer
Cancer ResearchOncology
2004English

Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Bevacizumab Improves Survival in Metastatic Colorectal Cancer Patients With Primary Tumor Resection: A Meta-Analysis

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy